Kazia Therapeutics (KZIA) Return on Assets (2009 - 2025)
Kazia Therapeutics (KZIA) reported Return on Assets of 0.0% for Q4 2025, little changed on a YoY basis from 0.0% in Q4 2024, and up 69.16% quarter-over-quarter from 0.0% in Q2 2025.
Kazia Therapeutics (KZIA) Return on Assets (2009 - 2025) Analysis & Trends
Kazia Therapeutics has reported Return on Assets for 14 years, with the latest figure at 0.0% in Q4 2025.
- For the quarter ending Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
- Return on Assets for Q4 2025 stood at 0.0%, up from 0.0% in the prior quarter.
- The five-year high for Return on Assets was 0.0% in Q4 2021, with the low at 0.0% in Q2 2025.
- Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2023.
- The largest YoY upside for Return on Assets was 0 bps in 2021 against a maximum downside of 0 bps in 2021.
- Kazia Therapeutics' Return on Assets stood at 0.0% in 2021, then sank by 81 bps to 0.0% in 2022, then declined by 23 bps to 0.0% in 2023, then slumped by 34 bps to 0.0% in 2024, then surged by 49 bps to 0.0% in 2025.
- The last three Return on Assets figures came in at 0.0% (Q4 2025), 0.0% (Q2 2025), and 0.0% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -0.01% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.01% |
| 10 | Kazia Therapeutics | 1.70 Bn | 1.70 Bn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |
| Dec 31, 2017 | 0.00% |
| Jun 30, 2017 | 0.00% |
| Dec 31, 2016 | 0.00% |
| Dec 31, 2012 | 0.00% |